Efficacy and Safety of Daily Risedronate in the Treatment of Corticosteroid-Induced Osteoporosis in Men and Women: A Randomized Trial-Reference-Cited by-同舟云学术

Efficacy and Safety of Daily Risedronate in the Treatment of Corticosteroid-Induced Osteoporosis in Men and Women: A Randomized Trial

Published:2000-06-01 Issue:6 Volume:15 Page:1006-1013
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Reid David M.,Hughes Rodney A.,Laan Roland F. J. M.,Sacco-Gibson Nancy A.,Wenderoth Dietrich H.,Adami Silvano,Eusebio Rachelle A.,Devogelaer Jean-Pierre

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Reference28 articles.

1. Glucocorticoid osteoporosis-mechanisms and management;Reid;Eur J Endocrinol,1997

2. Corticosteroid-induced osteoporosis;Adachi;Am J Med Sci,1997

3. Bone loss in response to long-term glucocorticoid therapy;LoCascio;Bone Miner,1990

4. Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis: A randomized, controlled study;Laan;Ann Intern Med,1993

5. Vertebral fractures in steroid dependent asthma and involutional osteoporosis: A comparative study;Luengo;Thorax,1991

Cited by 496 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Denosumab, teriparatide and bisphosphonates for glucocorticoid-induced osteoporosis: a Bayesian network meta-analysis;Frontiers in Pharmacology;2024-01-19

2. Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad?;Endocrine Reviews;2023-05-30

3. Association between bisphosphonate use and stroke risk: a meta-analysis;Osteoporosis International;2023-05-30

4. Bisphosphonate use for glucocorticoid-induced osteoporosis in older patients with immune thrombocytopenia: a clinical perspective;Annals of Hematology;2023-05-12

5. Threshold based on bone mineral density for therapeutic decision-making in postmenopausal women and men over 50 years old under glucocorticoid therapy;Reumatología Clínica;2023-05